Skip to content

Kort & Krachtig onderzoek (in Dutch).

Kort & Krachtig (in Dutch): A (cost) effectiveness study of brief interventions for mood and anxiety disorders: brief Routine Outcome Monitoring (ROM), intake & therapy.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON28797
Enrollment
500
Registered
2010-11-02
Start date
2010-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mood and/or anxiety disorders In dutch: stemmings- en/of angstklachten

Interventions

Intervention: Brief Cognitive Behavioural Therapy (CBT) and/or pharmacotherapy (SSRI). The brief CBT protocol is characterized by a quick onset and a maximum number of sessions (maximum 7 sessions wi

Sponsors

Leiden University Medical Centre (LUMC) Rivierduinen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male or female adolescents; 2. Adolescent between the ages of 18 and 65 year (inclusive) at the time of randomization; 3. Adolescent main complaint: anxiety and/or mood disorder; 4. Proper understanding of the Dutch language.

Exclusion criteria

Exclusion criteria: 1. Adolescents with main complaints other than anxiety and depression; 2. Adolescents with psychotic or bipolar traits; 3. Adolescents with suicidal or homicidal risk; 4. No proper understanding of the Dutch language; 5. Social disfunctioning.

Design outcomes

Primary

MeasureTime frame
Effectiveness of the intervention is investigated by the main questionnaires: 1. Web Screening Questionnaire (WSQ); 2. Brief Symptom Inventionary (BSI) as conducted by Routine Outcome Monitoring (ROM).

Secondary

MeasureTime frame
Secondary, cost-effectiveness is investigated by an open question version of the questionnaire Trimbos/iMTA Questionnaire for Cost associated with Psychiatric Illness (TIC-P). Additionally patient and clinicians satisfaction about the intervention is compared with treatment as usual by these main questionnaires.

Contacts

Public ContactD. Meuldijk

P.O. Box 9600

d.meuldijk@lumc.nl+31 (0)71 5261577

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)